Apolipoprotein E gene in Parkinson’s disease, Lewy body dementia and Alzheimer’s disease

  • D. St. Clair
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 51)


Apolipoprotein E (Apo E) epsilon 4 allele is a risk factor for early and late onset Alzheimer’s disease. This prompted us to examine other neurophyschiatric phenotypes. Epsilon 4 allele was significantly enriched in Lewy body dementia (N = 39) but not in Parkinson’s disease (n = 50) or Schizophrenia (n = 175) compared to aged non-demented controls (n = 47) and the Scottish population (n = 400). We conclude that Lewy body disease should be regarded as a variant of Alzheimer’s but not Parkinson’s disease.


Neurofibrillary Tangle Polymerase Chain Reac Lewy Body Disease Lewy Body Dementia Scottish Population 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Byrne EJ, Lennox G, Lowe J, et al. (1989) Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 52: 709–717.PubMedCrossRefGoogle Scholar
  2. Diedrich JF, Minnigan H, Carp RI, et al. (1991) Neuropathological changes in scrapie and Alzheimer’s disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65: 4759–4768.PubMedGoogle Scholar
  3. Dickson DW, Crystal H, Mattiace LA, et al. (1989) Diffuse Lewy body disease: light and electron microscopic immunohistochemistry of senile plaques. Acta Neuropathol 78: 572–84.PubMedCrossRefGoogle Scholar
  4. Goate A, Chartier HM, Mullan M, et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706.PubMedCrossRefGoogle Scholar
  5. Hansen L, Salmon D, Galasko D, et al. (1990) The Lewy body variant of Alzheimer’s disease: a clinical and pathological entity. Neurology 40: 1–8.PubMedCrossRefGoogle Scholar
  6. Hughes AJ, Daniel SE, Kilford L, et al. (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s’ disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181–184.PubMedCrossRefGoogle Scholar
  7. Levy-Lahad L, Wijsman EM, Nemens E, et al. (1995) A familial Alzheimer’s disease locus on chromosome 1. Science, 269: 980–997.Google Scholar
  8. Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson K (1990) Ubiquitin carboxyl terminal hydroxylase (PDP9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161: 153–160.PubMedCrossRefGoogle Scholar
  9. McKhann G, Drachman D, Folstein M, et al. (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group. Neurology 34: 939–944.PubMedCrossRefGoogle Scholar
  10. Namba Y, Tomonawa M, Kawasaki H, et al. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeld Jakob disease. Brain Res 541: 163–166.PubMedCrossRefGoogle Scholar
  11. Roses AD (1995) Apolipoprotein E genotyping in the differential diagnosis, not prediction of Alzheimer’s disease. Ann Neurol 38: 6–14.PubMedCrossRefGoogle Scholar
  12. Sherrington R, Rogaev EI, Liang Y, et al. (1995) Cloning of a gene bearing missense mutations in early onset familial Alzheimer’s disease. Nature 375: 754–760.PubMedCrossRefGoogle Scholar
  13. St Clair D, Norman J, Perry R, et al. (1994) Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer’s disease and age-matched controls. Neurosci Lett 176: 45–46.PubMedCrossRefGoogle Scholar
  14. St Clair D, Rennie M, Slorach. E, et al. (1995) Apolipoprotein E epsilon 4 allele is a risk factor for familial and sporadic presenile Alzheimer’s disease in both home and heterozygote carriers. J Med Gen 32: 642–644.CrossRefGoogle Scholar
  15. Strittmatter WJ, Saunders AM, Schmechel D, et al. (1993) Apolipoprotein E: high-avidity binding to ß-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977–1981.PubMedCrossRefGoogle Scholar
  16. Van Broeckhoven C (1995) The presenilins. Nature Genet 11: 230–232.PubMedCrossRefGoogle Scholar
  17. Wenham PR, Price WH, Blundell A (1991) Apolipoprotein E genotyping by one stage PCR. Lancet 337: 1158–1159.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1997

Authors and Affiliations

  • D. St. Clair
    • 1
  1. 1.Department of Mental HealthUniversity of AberdeenAberdeenUK

Personalised recommendations